NO-donor nitroglycerin versus the prostaglandin gemeprost for cervical ripening in first trimester missed abortion.
D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use*; D000030:Abortion, Missed / Q000188:drug therapy*; D000282:Administration, Intravaginal; D000328:Adult; D000527:Alprostadil / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D020070:Cervical Ripening / Q000187:drug effects*; D004107:Dilatation and Curettage / Q000295:instrumentation / Q000379:methods; D005260:Female; D005782:Gels; D006801:Humans; D020030:Nitric Oxide Donors / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000627:therapeutic use*; D017699:Pelvic Pain / Q000209:etiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011446:Prospective Studies; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use; D013488:Suppositories; D015149:Tocolytic Agents / Q000627:therapeutic use*; D014592:Uterine Hemorrhage / Q000209:etiology
D000020:Abortifacient Agents, Nonsteroidal; D005782:Gels; D020030:Nitric Oxide Donors; D011459:Prostaglandins E, Synthetic; D013488:Suppositories; D015149:Tocolytic Agents; C021182:gemeprost; D000527:Alprostadil; D005996:Nitroglycerin